• Explore /
  • Poster
  • / Randomized phase II study of WT1<span> peptide vaccine plus gemcitabine for advanced pancreatic ductal adenocarcinoma (PDAC): Clinical efficacy and immune response.</span.

Randomized phase II study of WT1 peptide vaccine plus gemcitabine for advanced pancreatic ductal adenocarcinoma (PDAC): Clinical efficacy and immune response.

Abstract Poster

Authors

null

Sumiyuki Nishida

Dept. of Respiratory Medicine, Allergy and Rheumatic Disease, Osaka University Graduate School of Medicine, Suita, Japan

Sumiyuki Nishida , Takeshi Ishikawa , Satoshi Kokura , Shinichi Egawa , Shigeo Koido , Hiroaki Yasuda , Hiroaki Yanagimoto , Jun Ishii , Yoshihide Kanno , Mari Saito Oba , Maho Sato , Soyoko Morimoto , Hidetoshi Eguchi , Hiroaki Nagano , Sadamu Homma , Yoshihiro Oka , Satoshi Morita , Haruo Sugiyama

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics and Translational Research

Sub Track

Vaccines

Clinical Trial Registration Number

UMIN000005248

Citation

J Clin Oncol 34, 2016 (suppl; abstr 3085)

DOI

10.1200/JCO.2016.34.15_suppl.3085

Abstract #

3085

Poster Bd #

407

Abstract Disclosures

Similar Posters

First Author: Jia Fan

First Author: Yoshihiro Yoshitake

First Author: Heike Richly

First Author: John Ebben